In January this year we had mentioned that a company called Churchill Pharmaceuticals was developing a new “submicron” formulation of abiraterone acetate. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abirateone, acetate, Churchill, FDA, Yonsa | 3 Comments »
Just as we have provided a recent update on the future potential of enzalutamide (MDV3100) in the treatment of prostate cancer, the following offers an update on the future potential of abiraterone acetate (Zytiga®). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Treatment | Tagged: abiraterone, acetate, development | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 